Denali Therapeutics Inc. (DNLI) Ownership

$19.96

$0.15 (-0.75%)
Last update: 04:00 PM EST
Day's range
$19.94
Day's range
$20.61

Denali Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 11/12/2025 12.29 M $178.45 M   1.96% 7.17%
VANGUARD GROUP INC 11/07/2025 11.99 M $174.14 M   1.54% 7.00%
BAILLIE GIFFORD & CO 10/31/2025 11.59 M $168.31 M   -3.04% 6.76%
FMR LLC 11/13/2025 6.34 M $92.06 M   -15.89% 3.70%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 11/14/2025 5.64 M $81.87 M   73.66% 3.29%
UBS ASSET MANAGEMENT AMERICAS INC 11/14/2025 5.47 M $79.35 M   -12.73% 3.19%
STATE STREET CORP 11/14/2025 5.46 M $79.34 M   20.94% 3.19%
TEMASEK HOLDINGS (PRIVATE) LTD 11/14/2025 5.36 M $77.77 M   0.00% 3.12%
CAPITAL RESEARCH GLOBAL INVESTORS 11/13/2025 4.76 M $69.13 M   0.22% 2.78%
PRICE T ROWE ASSOCIATES INC /MD/ 11/14/2025 4.57 M $66.33 M   -30.60% 2.66%
BAKER BROS. ADVISORS LP 11/14/2025 3.73 M $54.18 M   0.00% 2.18%
ALLIANCEBERNSTEIN L.P. 11/14/2025 3.52 M $51.12 M   12.22% 2.05%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 3.47 M $50.34 M   9.26% 2.02%
CRESTLINE MANAGEMENT, LP 11/14/2025 3.41 M $49.52 M   -11.66% 1.99%
HOLOCENE ADVISORS, LP 11/14/2025 3.14 M $45.53 M   677.76% 1.83%
POINT72 ASSET MANAGEMENT, L.P. 11/14/2025 2.52 M $36.58 M   13.80% 1.47%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 2.36 M $34.23 M   -2.31% 1.37%
GOLDMAN SACHS GROUP INC 11/14/2025 2.16 M $31.42 M   16.00% 1.26%
UBS GROUP AG 11/13/2025 2.01 M $29.22 M   111.66% 1.17%
STEMPOINT CAPITAL LP 11/14/2025 1.73 M $25.19 M   145.04% 1.01%
MORGAN STANLEY 11/14/2025 1.69 M $24.53 M   28.77% 0.99%
FISHER ASSET MANAGEMENT, LLC 11/12/2025 1.63 M $23.69 M   7.62% 0.95%
MILLENNIUM MANAGEMENT LLC 11/14/2025 1.31 M $18.98 M   45.16% 0.76%
PRINCIPAL FINANCIAL GROUP INC 11/04/2025 1.27 M $18.46 M   18.47% 0.74%
NORTHERN TRUST CORP 11/14/2025 1.23 M $17.92 M   2.70% 0.72%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 1.15 M $16.72 M   9.03% 0.67%
ABRDN PLC 11/07/2025 1.11 M $16.17 M   23.35% 0.65%
FORESITE CAPITAL MANAGEMENT VI LLC 11/14/2025 1.00 M $14.52 M   100.00% 0.58%
BANK OF AMERICA CORP /DE/ 11/14/2025 961.14 K $13.96 M   47.82% 0.56%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 11/14/2025 936.23 K $13.59 M   21.51% 0.55%
CASDIN CAPITAL, LLC 11/14/2025 890.00 K $12.92 M   0.00% 0.52%
CANDRIAM S.C.A. 11/06/2025 833.58 K $12.10 M   -1.26% 0.49%
SIREN, L.L.C. 11/13/2025 821.51 K $11.93 M   0.00% 0.48%
BANK OF NEW YORK MELLON CORP 11/03/2025 800.75 K $11.63 M   1.26% 0.47%
MARSHALL WACE, LLP 11/13/2025 787.03 K $11.43 M   -43.99% 0.46%
MASTERS CAPITAL MANAGEMENT LLC 11/14/2025 750.00 K $10.89 M   25.00% 0.44%
CITADEL ADVISORS LLC 11/14/2025 688.22 K $9.99 M   -44.90% 0.40%
CERCANO MANAGEMENT LLC 11/07/2025 625.00 K $9.08 M   0.00% 0.36%
ENSIGN PEAK ADVISORS, INC 11/13/2025 534.07 K $7.75 M   12.75% 0.31%
SEGALL BRYANT & HAMILL, LLC 11/12/2025 512.96 K $7.45 M   2.48% 0.30%
PICTET ASSET MANAGEMENT HOLDING SA 11/18/2025 499.16 K $7.25 M   20.25% 0.29%
YIHENG CAPITAL MANAGEMENT, L.P. 11/14/2025 469.98 K $6.82 M   0.00% 0.27%
BARCLAYS PLC 11/12/2025 437.00 K $6.35 M   2.59% 0.25%
TREXQUANT INVESTMENT LP 11/14/2025 430.57 K $6.25 M   294.14% 0.25%
PALO ALTO INVESTORS LP 11/14/2025 408.01 K $5.92 M   70.14% 0.24%
TD ASSET MANAGEMENT INC 11/10/2025 394.60 K $5.73 M   -20.49% 0.23%
ROYAL BANK OF CANADA 11/14/2025 372.18 K $5.40 M   -4.61% 0.22%
CLARIUS GROUP, LLC 10/14/2025 359.75 K $5.22 M   -2.51% 0.21%
AMERICAN CENTURY COMPANIES INC 11/12/2025 357.34 K $5.19 M   12.30% 0.21%
HUDSON BAY CAPITAL MANAGEMENT LP 11/13/2025 305.00 K $4.43 M   5.17% 0.18%

Denali Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 311 institutional investors and hedge funds held shares of Denali Therapeutics Inc.. The most heavily invested institutionals were:

BlackRock, Inc.: 12.29 M

VANGUARD GROUP INC: 11.99 M

BAILLIE GIFFORD & CO: 11.59 M

FMR LLC: 6.34 M

T. Rowe Price Investment Management, Inc.: 5.64 M

UBS ASSET MANAGEMENT AMERICAS INC: 5.47 M

79.04% of Denali Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 158.19 M shares in the last 24 months. This purchase volume represents approximately $3.16 B in transactions.